Matsukawa Hidetoshi, Kamiyama Hiroyasu, Miyazaki Takanori, Kinoshita Yu, Ota Nakao, Noda Kosumo, Shonai Takaharu, Takahashi Osamu, Tokuda Sadahisa, Tanikawa Rokuya
Department of Neurosurgery, Stroke Center, Teishinkai Hospital, Sapporo, Japan.
Department of Radiology, Teishinkai Hospital, Sapporo, Japan.
World Neurosurg. 2018 Sep;117:e563-e570. doi: 10.1016/j.wneu.2018.06.077. Epub 2018 Jun 19.
Regardless of acceptable surgical results of middle cerebral artery aneurysms (MCAs), MCA territory infarction (MCATI) remains a major obstacle to achieving a good outcome. We investigated the MCATI in patients with surgically treated MCA aneurysms.
The data of 286 consecutive patients with 322 MCA aneurysms were evaluated retrospectively. The aneurysm location was classified as early frontal cortical branch (EFCB), early temporal cortical branch (ETCB), bifurcation or trifurcation (M1-2), and distal aneurysms on the insular, opercular, or cortical segments of the MCA (distal MCA). Neurologic worsening was defined as an increase in 1 or more modified Rankin Scale (mRS) scores.
Multivariate analysis identified EFCB location as the sole risk factor for MCATI (odds ratio [OR], 3.8; 95% confidence interval [CI], 1.2-12; P = 0.021) and MCATI (OR, 18; 95% CI, 2.8-117; P = 0.002) and a larger size ratio (OR, 1.4; 95% CI, 1.1-1.8; P = 0.019) were related to 12-month neurologic worsening (n = 6; 1.9%). During follow-up (median, 885 days; interquartile range, 485-1229 days), posttreatment rupture and aneurysm recurrence were not observed.
In the present study, compared with M1-2 aneurysms, MCATIs were observed more frequently in EFCB aneurysms, and the presence of MCATI and a larger size ratio were related to 12-month neurologic worsening in patients with surgically treated MCA aneurysms.
尽管大脑中动脉动脉瘤(MCA)的手术效果尚可,但MCA区域梗死(MCATI)仍然是实现良好预后的主要障碍。我们对接受手术治疗的MCA动脉瘤患者的MCATI情况进行了调查。
回顾性评估了286例连续患者的322个MCA动脉瘤的数据。动脉瘤位置分为早期额叶皮质分支(EFCB)、早期颞叶皮质分支(ETCB)、分叉或三叉(M1-2)以及MCA岛叶、脑盖或皮质段的远端动脉瘤(远端MCA)。神经功能恶化定义为改良Rankin量表(mRS)评分增加1分或更多。
多因素分析确定EFCB位置是MCATI的唯一危险因素(比值比[OR],3.8;95%置信区间[CI],1.2-12;P = 0.021),且MCATI(OR,18;95%CI,2.8-117;P = 0.002)和较大的大小比(OR,1.4;95%CI,1.1-1.8;P = 0.019)与12个月时的神经功能恶化相关(n = 6;1.9%)。在随访期间(中位时间,885天;四分位间距,485-1229天),未观察到治疗后破裂和动脉瘤复发。
在本研究中,与M1-2动脉瘤相比,EFCB动脉瘤中MCATI更为常见,且MCATI的存在和较大的大小比与接受手术治疗的MCA动脉瘤患者12个月时的神经功能恶化相关。